CY1112554T1 - Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης - Google Patents

Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης

Info

Publication number
CY1112554T1
CY1112554T1 CY20111100969T CY111100969T CY1112554T1 CY 1112554 T1 CY1112554 T1 CY 1112554T1 CY 20111100969 T CY20111100969 T CY 20111100969T CY 111100969 T CY111100969 T CY 111100969T CY 1112554 T1 CY1112554 T1 CY 1112554T1
Authority
CY
Cyprus
Prior art keywords
benzoylaminophenyl
dimethoxy
methyl
quinazoline derivative
optionally substituted
Prior art date
Application number
CY20111100969T
Other languages
English (en)
Inventor
Kazuki Miyazaki
Kazutomi Kusano
Yasutaka Takase
Osamu Asano
Manabu Shirato
Hisashi Wakita
Naoto Ishii
Takao Saeki
Original Assignee
Eisai R&D Management Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07714569A external-priority patent/EP1992622B1/en
Application filed by Eisai R&D Management Co., Ltd filed Critical Eisai R&D Management Co., Ltd
Publication of CY1112554T1 publication Critical patent/CY1112554T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Abstract

Ένωση που αντιπροσωπεύεται από τον ακόλουθο τύπο (Ι), άλας αυτής ή υδρίτης αυτής, που μπορεί ικανοποιητικά να ανακουφίζει φαγούρα που προκαλείται από ατοπική ασθένεια ή τα παρόμοια :
CY20111100969T 2006-02-21 2011-10-10 Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης CY1112554T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21
EP07714569A EP1992622B1 (en) 2006-02-21 2007-02-20 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative

Publications (1)

Publication Number Publication Date
CY1112554T1 true CY1112554T1 (el) 2016-02-10

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100969T CY1112554T1 (el) 2006-02-21 2011-10-10 Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης

Country Status (18)

Country Link
JP (1) JP4778550B2 (el)
KR (1) KR101278852B1 (el)
AT (1) ATE517875T1 (el)
BR (1) BRPI0708098B8 (el)
CY (1) CY1112554T1 (el)
DK (1) DK1992622T3 (el)
ES (1) ES2368089T3 (el)
HK (1) HK1122025A1 (el)
HR (1) HRP20110604T1 (el)
IL (1) IL193322A (el)
JO (1) JO2726B1 (el)
MY (1) MY146275A (el)
NZ (1) NZ569936A (el)
PT (1) PT1992622E (el)
RS (1) RS51969B (el)
RU (1) RU2431632C2 (el)
SI (1) SI1992622T1 (el)
TW (1) TWI404709B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123641A4 (en) 2007-02-16 2011-06-22 Eisai R&D Man Co Ltd CRYSTAL, AMORPHOUS FORM AND METHYL N-Ý3- (6,7-DIMETHOXY-2-METHYLAMINOQUINAZOLINE-4-YL) PHENYLENE TEREPHTALIC ACID SALT
KR20100042246A (ko) 2007-08-17 2010-04-23 에자이 알앤드디 매니지먼트 가부시키가이샤 신규 외용제
CN102336717B (zh) 2007-08-17 2013-09-18 卫材R&D管理有限公司 喹唑啉衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬

Also Published As

Publication number Publication date
SI1992622T1 (sl) 2011-11-30
HRP20110604T1 (hr) 2011-09-30
BRPI0708098B8 (pt) 2021-05-25
IL193322A (en) 2014-04-30
TW200812980A (en) 2008-03-16
NZ569936A (en) 2010-07-30
KR20080094811A (ko) 2008-10-24
PT1992622E (pt) 2011-09-19
IL193322A0 (en) 2009-05-04
MY146275A (en) 2012-07-31
ATE517875T1 (de) 2011-08-15
RU2431632C2 (ru) 2011-10-20
JP4778550B2 (ja) 2011-09-21
BRPI0708098A2 (pt) 2011-05-17
ES2368089T3 (es) 2011-11-14
RU2008137654A (ru) 2010-03-27
BRPI0708098B1 (pt) 2019-08-06
JPWO2007097317A1 (ja) 2009-07-16
JO2726B1 (en) 2013-09-15
RS51969B (en) 2012-02-29
HK1122025A1 (el) 2009-05-08
KR101278852B1 (ko) 2013-07-01
DK1992622T3 (da) 2011-09-05
TWI404709B (zh) 2013-08-11

Similar Documents

Publication Publication Date Title
AR110313A2 (es) Derivados de tiazol-2-il-pirrolidina
MY148703A (en) Polycyclic cinnamide derivatives
MY150507A (en) Polycyclic compound
MY150989A (en) Benzothiazole compounds useful for raf inhibition
HRP20120323T1 (en) Diarylhydantoin compounds
CY1111671T1 (el) Ετεροκυκλικη ενωση
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
MY158982A (en) Heterocyclic compound
WO2009028629A1 (ja) 複素環化合物およびその用途
RS53003B (en) C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
BRPI0914772A2 (pt) compostos heterocíclicos 1,2-dissubstituídos
MX342064B (es) Novedoso compuesto de imidazo-oxazina o sal del mismo.
WO2008019395A3 (en) Compounds for improving learning and memory
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
AU2012310674B2 (en) Radioactive fluorine labeled compound
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
EA201071424A1 (ru) Сульфонатные соли 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина
CY1112554T1 (el) Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης
WO2006078984A3 (en) Uses of methylphenidate derivatives
MY158199A (en) Substituted pyridine compound
RS53747B1 (en) FENANTRENON UNITS, COMPOSITIONS AND METHODS
MX2010013184A (es) Compuesto heterocíclico.
TW200634000A (en) 2-(pyrazol-1-yl)pyridine derivatives